Tag: Paul Ehrlich
All products of the creative process are a reflection of the individual makeup of the inventors. A painting by Mark Rothko looks like a...
Antibody-drug conjugates or ADCs are creating much excitement among life science professionals, medical/clinical research scientists and pharmaceutical specialists. At the same time, oncologists and hematologists are eager to welcome new treatment options in the ongoing war against cancer. This article reviews some of the advances made in the development of ADCs.